Dear partners & colleagues,

 

what are the new promising trends in science and industry? How is the production process of biotechnological and pharmaceutical products going to change in the future? How can we as a society benefit from new, environmentally friendly innovations, and what are the expectation and challenges?

 

The second European Summit of Industrial Biotechnology (esib) focusses on "PRODUCTS & PRODUCTION" and not only discusses innovative scientific research, but also industrial needs and hopes as well as funding resources. It will take place in Graz from November 14 - 16, 2017. Please find the program enclosed.

 

The program consists of 25 sessions including top-class speakers from science, industry and funding agencies. It is complimented by a unique social program to encourage communication & networking like the Gala Academia on top of the Schlossberg and the Chilling Life Science - everything is already included in the participation fee.

Benefit from new formats like „Pitch your Research“, „Scientific Storytelling“ or our B2B partnering event.

 

Meet representatives from global key players like BASF, Bayer, Boehringer-Ingelheim, Clariant, DSM, Firmenich, Fresenius, GSK, G.L. Pharma, GE Healthcare, Givaudan, Jungbunzlauer, Lonza, Merck, Novartis, Novozymes, Patheon, Sandoz, Shire, Siemens, Wuxi etc.

The deadline for the early bird registration is approaching soon by August 31, 2017.

Registration for poster abstract submissions and speed presentations is ending by September 30, 2017. Therefore, seize the opportunity and register now!

esib – science meets economy meets politics

November 14 to 16, 2017, Graz, Austria

www.esib.at

esib is the European platform for communication and networking for industrial biotechnology.

 

We invite you to seize the opportunity to discuss vital questions and encouraging topics and to be on top of new insights and trends!

 

Best regards,

Bernd Nidetzky on behalf of the Scientific Committee